DB01535

GPTKB entity

Statements (48)
Predicate Object
gptkbp:instanceOf gptkb:drug
gptkbp:approvalYear 2004
gptkbp:approvedBy gptkb:FDA
gptkbp:ATCCode gptkb:N06AX21
gptkbp:bioavailability 50%
gptkbp:brand gptkb:Cymbalta
Irenka
gptkbp:CASNumber gptkb:136434-34-9
gptkbp:contraindication gptkb:Uncontrolled_narrow-angle_glaucoma
Concomitant use with MAO inhibitors
gptkbp:eliminationHalfLife 12 hours
gptkbp:excretion Urine
gptkbp:hasChEMBL CHEMBL117
gptkbp:hasDrugBankCategory Antidepressant
Serotonin and norepinephrine reuptake inhibitor
gptkbp:hasInChIKey YGYULZCUIZJXSS-UHFFFAOYSA-N
gptkbp:hasMolecularFormula gptkb:C18H19NOS
gptkbp:hasSMILES CN(C)CCOC1=CC=CC=C1C2=CC=CC=C2S
gptkbp:hasUNII O5TNM5N07U
https://www.w3.org/2000/01/rdf-schema#label DB01535
gptkbp:indication gptkb:Chronic_musculoskeletal_pain
gptkb:Diabetic_peripheral_neuropathic_pain
gptkb:Major_depressive_disorder
Fibromyalgia
Generalized anxiety disorder
gptkbp:legalStatus Prescription only
Patent expired
gptkbp:manufacturer gptkb:Eli_Lilly_and_Company
gptkbp:mechanismOfAction Inhibits reuptake of serotonin and norepinephrine
gptkbp:metabolism gptkb:Hepatic_(CYP1A2,_CYP2D6)
gptkbp:molecularWeight 297.42
gptkbp:name gptkb:Duloxetine
gptkbp:pregnancyCategory C (US)
gptkbp:proteinBinding 95%
gptkbp:PubChem_CID 60835
D07861
CHEBI:36796
gptkbp:routeOfAdministration gptkb:Oral
gptkbp:sideEffect gptkb:Nausea
gptkb:Somnolence
Constipation
Dry mouth
Increased sweating
Decreased appetite
gptkbp:target SLC6A2 (norepinephrine transporter)
SLC6A4 (serotonin transporter)
gptkbp:bfsParent gptkb:D006_Heroin
gptkbp:bfsLayer 7